Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ORIC Pharmaceuticals, Inc.(ORIC) | 5,376,344 | 4,780,401 | -595,943 | $43.98M | $57.65M | 24.14% | +$13.67M |
| Allogene Therapeutics Inc | 22,032,040 | 22,032,040 | 0 | $30.18M | $49.79M | 20.85% | +$19.61M |
| Arvinas, Inc.(ARVN) | 3,457,815 | 3,457,815 | 0 | $41.01M | $34.92M | 14.63% | -$6.09M |
| Celcuity Inc.(CELC) | 349,406 | 295,652 | -53,754 | $34.85M | $31.35M | 13.13% | -$3.50M |
| Zura Bio LimitedCL A(ZURA) | 2,970,022 | 2,838,913 | -131,109 | $15.56M | $16.83M | 7.05% | +$1.27M |
| Wave Life Sciences, Inc.SHS(WVE) | 1,875,000 | 1,875,000 | 0 | $31.88M | $11.93M | 5.00% | -$19.94M |
| Pyxis Oncology, Inc.(PYXS) | 7,032,770 | 7,032,770 | 0 | $8.09M | $9.21M | 3.86% | +$1.13M |
| Caribou Biosciences, Inc.(CRBU) | 4,690,431 | 4,690,431 | 0 | $7.46M | $8.35M | 3.50% | +$891.2K |
| Spero Therapeutics, Inc.(SPRO) | 2,362,348 | 2,362,348 | 0 | $5.50M | $5.50M | 2.31% | $0 |
| Biohaven Ltd.(BHVN) | 505,645 | 505,645 | 0 | $5.71M | $4.23M | 1.77% | -$1.48M |
| Cardiff Oncology, Inc.(CRDF) | 2,411,575 | 2,411,575 | 0 | $6.78M | $3.74M | 1.57% | -$3.04M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 953,834 | 953,834 | 0 | $1.29M | $2.00M | 0.84% | +$715.4K |
| Nextcure Inc | 157,646 | 153,354 | -4,292 | $2.24M | $1.54M | 0.64% | -$701.9K |
| AgomAb Therapeutics NVADS(AGMB) | 0 | 75,000 | +75,000 | $0 | $813.8K | 0.34% | +$813.8K |
| Q32 Bio Inc.(QTTB) | 277,777 | 101,618 | -176,159 | $922.2K | $736.7K | 0.31% | -$185.5K |
| Bolt Biotherapeutics Inc | 31,305 | 31,305 | 0 | $171.2K | $137.1K | 0.06% | -$34.1K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 2,928 | 2,928 | 0 | $24.3K | $17.4K | 0.01% | -$7.0K |
| Senseonics Holdings, Inc.(SENS) | 2,171 | 2,171 | 0 | $12.0K | $14.2K | 0.01% | +$2.3K |
| An2 Therapeutics Inc | 715,295 | 0 | -715,295 | $815.4K | $0 | — | -$815.4K |